Correspondence on 'Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a patient with COVID-19 with psoriatic arthritis receiving ustekinumab'.

Messina, Francesco; Pampaloni, Francesca; Piaserico, Stefano

Messina, Francesco; Pampaloni, Francesca; Piaserico, Stefano.

Messina F; Dermatology Unit, Department of Medicine, University of Padova, Padova, Italy.
Pampaloni F; Dermatology Unit, Department of Medicine, University of Padova, Padova, Italy.
Piaserico S; Dermatology Unit, Department of Medicine, University of Padova, Padova, Italy stefano.piaserico@gmail.com.

Ann Rheum Dis ; 80(5): e79, 2021 05.

Article in English | MEDLINE | ID: covidwho-1180921

Subject(s)

Antirheumatic Agents; Arthritis, Psoriatic; COVID-19; Spondylarthritis; Antirheumatic Agents/therapeutic use; Arthritis, Psoriatic/drug therapy; Etanercept/therapeutic use; Humans; SARS-CoV-2; Spondylarthritis/drug therapy; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Ustekinumab/therapeutic use

Keywords

arthritis, psoriatic; biological therapy; cytokines; inflammation; therapeutics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Psoriatic / Antirheumatic Agents / Spondylarthritis / COVID-19 Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2020-218029

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google